Drug intelligence / Profile preview

Renoskin

Development stage: Unknown
Lead developer: Galenium Pharmasia
Modality: Small Molecules
Administration: Implant

Overview

Renoskin is a topical ointment primarily used for the treatment and prevention of diaper rash, minor burns, and other skin irritations. It is a combination product containing zinc oxide and cod liver oil. Zinc oxide acts as a physical barrier and skin protectant, providing a soothing effect and promoting healing by creating a moisture-resistant layer on the skin. Cod liver oil, rich in vitamins A and D, supports skin regeneration and maintains skin integrity. The formulation is designed to protect the skin from irritants such as moisture, urine, and fecal matter, while facilitating the natural repair process of the epidermis.

Brand names: Renoskin
Other names: zinc oxide + cod liver oil ointment

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Renoskin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renoskin.

Explore the full profile